Skip to main content

RHUMBLINE ADVISERS

Position in ANIK — Anika Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in ANIK

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$239,112
-$5,372 QoQ
Shares Held
16,344
-3.1% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 134 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 20% Shared 0% None 80%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. ANIK ranks #37 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANIK

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $239,112 16,344
2026-03-31 $244,484 16,861
2025-12-31 $174,373 18,145
2025-09-30 $190,998 20,319
2025-06-30 $224,571 21,226
2025-03-31 $317,298 21,111
2024-12-31 $366,185 22,247
2024-09-30 $552,193 22,356
2024-06-30 $613,771 24,231
2024-03-31 $615,899 24,248
2023-12-31 $571,009 25,199
2023-09-30 $484,957 26,031
2023-06-30 $1,343,503 51,713
2023-03-31 $1,416,527 49,322
2022-12-31 $1,356,420 45,825
2022-09-30 $1,078,544 45,317
2022-06-30 $977,950 43,815
2022-03-31 $1,081,136 43,056
2021-12-31 $1,506,400 42,043
2021-09-30 $1,802,416 42,350
2021-06-30 $2,027,010 46,824
2021-03-31 $2,069,113 50,726
2020-12-31 $2,197,146 48,545
2020-09-30 $1,546,224 43,691
2020-06-30 $1,757,614 46,584
2020-03-31 $1,449,720 50,146